Millennial Dominance in B2B Decision Making

The global pharmaceutical CRO market continues to demonstrate robust expansion, driven by increasing complexities in clinical trials, surging R&D expenditures, and evolving regulatory landscapes. Valued at USD 40 billion in 2023, the market is projected to reach USD 75.7 billion by 2032, growing at a CAGR of 7.36% from 2024 to 2032, according to the latest industry analysis. The...